Chronic hypnotic use at 10 years—does the brand matter?
Chronic use of sedative-hypnotics is very common, although not guideline-endorsed. The incidence among new users is not well studied, and there are currently no recommendations favoring any specific agent. We quantified the risk for chronic use in first-time hypnotic users, and the association of the initial choice of hypnotic with later usage patterns.
We used the computerized database of Israel’s largest healthcare provider. All 236,597 new users of sedative-hypnotics between the years 2000–2005 were followed for 10 years. Filled prescriptions in the second, fifth, and tenth years were recorded. The association of the first hypnotic choice (benzodiazepine/Z-drug) with chronic consumption was assessed using multivariate logistic regression.
Average age on first use was 63.7 (SD ± 16.4) years. 58.6% were women. Benzodiazepines were initiated in 154,929 (65.5%) of the cases. Benzodiazepine users were older and of lower socioeconomic status, compared to Z-drug users (p < 0.001). On the tenth year, 103,912 (66.8%) of new users claimed ≤ 30 DDDs of hypnotics, 3,1724 (20.4%) were long-term users (≥ 180 DDD/year), and 828 (0.5%) used excessively (≥ 720 DDD/year). Z-drugs were associated with an increased risk of long-term use on the second year [17.3% vs. 12.4%, RR = 1.40 (1.37–1.43)] as well as on the fifth [21.9% vs. 13.9%, RR = 1.58 (1.55–1.61)] and tenth year [25.1% vs. 17.7%, RR = 1.42 (1.39–1.45)], p < 0.0001. Similar results were also observed for daily and excessive use (p < 0.001).
One in five new users of sedative-hypnotics will become a long-term user, but only 0.5% will become excessive users. Z-drugs were associated with an increased risk of chronic use.
Keywords(MESH) Benzodiazepines Zolpidem Zopiclone Hypnotics and sedatives Drug tolerance Adult Drug dependence Risk Sleep initiation and maintenance disorders Insomnia
Compliance with ethical standards
Ethical approval was obtained from the CHS institutional ethics review board.
- 2.Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Gonçalves M, Hertenstein E, Jansson-Fröjmark M, Jennum PJ, Leger D, Nissen C, Parrino L, Paunio T, Pevernagie D, Verbraecken J, Weeß HG, Wichniak A, Zavalko I, Arnardottir ES, Deleanu OC, Strazisar B, Zoetmulder M, Spiegelhalder K (2017) European guideline for the diagnosis and treatment of insomnia. J Sleep Res 26:675–700. https://doi.org/10.1111/jsr.12594 CrossRefPubMedGoogle Scholar
- 3.Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, for the Clinical Guidelines Committee of the American College of Physicians (2016) Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians. Ann Intern Med 165:125–133. https://doi.org/10.7326/M15-2175 CrossRefPubMedGoogle Scholar
- 5.Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med J Clin Sleep Med J Clin Sleep Med 1313:307–349. https://doi.org/10.5664/jcsm.6470 CrossRefGoogle Scholar
- 8.Kurko TAT, Saastamoinen LK, Tähkäpää S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J (2015) Long-term use of benzodiazepines: definitions, prevalence and usage patterns – a systematic review of register-based studies. Eur Psychiatry 30:1037–1047. https://doi.org/10.1016/j.eurpsy.2015.09.003 CrossRefPubMedGoogle Scholar
- 9.Anthierens S, Pasteels I, Habraken H et al (2010) Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: family physicians’ attitudes toward benzodiazepine prescribing. Can Fam physician Médecin Fam Can 56:e398–e406Google Scholar
- 10.Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN (2013) General practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract 14:191. https://doi.org/10.1186/1471-2296-14-191 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Everitt H, Mcdermott L, Leydon G et al (2014) GPs’ management strategies for patients with insomnia : 112–119. https://doi.org/10.3399/bjgp14X677176.Conclusion
- 12.Campanelli CM (2013) American Geriatrics Society Updated Beers Criteria for potentially inappropriate medication use in older adults: the American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc 60:616–631Google Scholar
- 13.Oecd (2015) Health at a glance 2015. OECD PublishingGoogle Scholar
- 18.Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN (2012) Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ 345:e8343. https://doi.org/10.1136/bmj.e8343 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group (2008) Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79–90CrossRefGoogle Scholar
- 26.Wilson S, Nutt D, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG (2010) British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 24:1577–1601. https://doi.org/10.1177/0269881110379307 CrossRefPubMedGoogle Scholar
- 29.Ford ES, Wheaton AG, Cunningham TJ, Giles WH, Chapman DP, Croft JB (2014) Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care Survey 1999-2010. Sleep 37:1283–1293. https://doi.org/10.5665/sleep.3914 CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL (2016) Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American college of physicians. Ann Intern Med 165:103–112. https://doi.org/10.7326/M15-1781 CrossRefPubMedGoogle Scholar
- 31.OECD (2012) OECD reviews of health care quality: Israel 2012. OECD PublishingGoogle Scholar
- 32.The Israel Drug Registry. http://www.old.health.gov.il/units/pharmacy/trufot/index.asp?safa=e. Accessed 13 Apr 2016
- 34.WHO Collaborating Centre for Drug Statistics Methodology (2016) Guidelines for ATC classification and DDD assignment 2016. Oslo. . OsloGoogle Scholar
- 36.Manor O (2015) Program for quality indicators in community healthcare in Israel Report 2013-2014Google Scholar
- 37.Cloos J-M, Bocquet V, Rolland-Portal I, Koch P, Chouinard G (2015) Hypnotics and triazolobenzodiazepines – best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry. Psychother Psychosom 84:273–283. https://doi.org/10.1159/000434755 CrossRefPubMedGoogle Scholar
- 38.Tvete IF, Bjørner T, Aursnes IA, Skomedal T (2013) A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing. BMJ Open 3:e003296. https://doi.org/10.1136/bmjopen-2013-003296 CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Norton EC, Miller MM, Kleinman LC (2013) Computing adjusted risk ratios and risk differences in Stata. Stata J 13:492–509Google Scholar
- 42.Cohen R, Rabin H (2015) Membership in sick funds 2014 [Hebrew]. JerusalemGoogle Scholar
- 52.Yen CF, Ko CH, Chang YP, Yu CY, Huang MF, Yeh YC, Lin JJ, Chen CS (2015) Dependence, misuse, and beliefs regarding use of hypnotics by elderly psychiatric patients taking zolpidem, estazolam, or flunitrazepam. Asia Pac Psychiatry 7:298–305. https://doi.org/10.1111/appy.12147 CrossRefPubMedGoogle Scholar
- 54.Ayalon L, Gross R, Yaari A, Feldhamer E, Balicer RD, Goldfracht M (2013) Patients’ and physicians’ characteristics associated with the purchase of benzodiazepines by older primary care patients in Israel. Admin Pol Ment Health 40:117–123. https://doi.org/10.1007/s10488-011-0381-9 CrossRefGoogle Scholar